These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 2530532)
1. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae]. Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532 [TBL] [Abstract][Full Text] [Related]
2. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase]. Bercion R; Meyran M; Labia R; Thabaut A Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669 [TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum]. Cavallo JD; Fabre R; Crenn Y; Meyran M Pathol Biol (Paris); 1994 May; 42(5):365-8. PubMed ID: 7824297 [TBL] [Abstract][Full Text] [Related]
4. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital]. Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338 [TBL] [Abstract][Full Text] [Related]
5. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. de Champs C; Sirot D; Chanal C; Poupart MC; Dumas MP; Sirot J J Antimicrob Chemother; 1991 Apr; 27(4):441-57. PubMed ID: 1856124 [TBL] [Abstract][Full Text] [Related]
6. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Jarlier V; Nicolas MH; Fournier G; Philippon A Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690 [TBL] [Abstract][Full Text] [Related]
7. Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Ma L; Chang FY; Fung CP; Chen TL; Lin JC; Lu PL; Huang LY; Chang JC; Siu LK Microb Drug Resist; 2005; 11(1):31-9. PubMed ID: 15770092 [TBL] [Abstract][Full Text] [Related]
8. [Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases]. Thabaut A; Meyran M Pathol Biol (Paris); 1990 May; 38(5):347-51. PubMed ID: 2195446 [TBL] [Abstract][Full Text] [Related]
9. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A; J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502 [TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins. Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939 [TBL] [Abstract][Full Text] [Related]
13. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160 [TBL] [Abstract][Full Text] [Related]
14. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases. Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086 [TBL] [Abstract][Full Text] [Related]
15. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains. Castanheira M; Mills JC; Costello SE; Jones RN; Sader HS Antimicrob Agents Chemother; 2015; 59(6):3509-17. PubMed ID: 25845862 [TBL] [Abstract][Full Text] [Related]
16. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. Queenan AM; Foleno B; Gownley C; Wira E; Bush K J Clin Microbiol; 2004 Jan; 42(1):269-75. PubMed ID: 14715764 [TBL] [Abstract][Full Text] [Related]
17. [Enzymatic resistance to cefotaxime in 56 strains of Klebsiella spp., Escherichia coli and Salmonella spp. at a Tunisian hospital (1984-1988)]. Ben Hassen A; Fournier G; Kechrid A; Fendri C; Ben Redjeb S; Philippon A Pathol Biol (Paris); 1990 May; 38(5):464-9. PubMed ID: 2195457 [TBL] [Abstract][Full Text] [Related]
18. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles]. Oksüz L; Gürler N Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the antibacterial activity of cefpodoxime against enterobacteria producing beta lactamases]. Siebor E; Cordin X; Delpech N; Duez JM; Kazmierczak A Pathol Biol (Paris); 1990 May; 38(5):331-5. PubMed ID: 2367149 [TBL] [Abstract][Full Text] [Related]